Lundbeckfonden Emerge

What they do

Lundbeckfonden BioCapital is the dedicated biotech investment arm of the Lundbeck Foundation, one of Denmark's largest enterprise foundations with roughly DKK 72 billion in total assets. Formed in 2022 from the merger of Lundbeckfonden Emerge and Lundbeckfonden Ventures, the unit operates as an evergreen fund, allowing it to provide patient capital without the strict exit timelines of traditional 10-year VC funds. The firm is highly regarded in the European life sciences ecosystem for its deep domain expertise, hands-on operational support, and its strategic mandate to double the size of its Danish biotech portfolio by 2030 while generating top-tier financial returns.

What they look for

The firm's ambition is to identify scientific breakthroughs and develop new, groundbreaking medicines, generating an attractive financial return while supporting the growth of the Danish biotech ecosystem and building long-term sustainable businesses.

Stage

Pre-seed, Seed, Series A, Series B+

Sectors

Healthcare, Deeptech, AI

Based

Copenhagen, DK